# Intraoperative Dexamethasone in Pediatric Cardiac Surgery

Study · id `cardio:ct-nct02615262` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02615262](<https://clinicaltrials.gov/study/NCT02615262>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02615262

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 394 participants.

## Technical summary

Registry record NCT02615262. Randomized; triple masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2018-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 394 participants (enrolled count; ClinicalTrials.gov record NCT02615262, source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)
- Started: 2015-12 (actual) (ClinicalTrials.gov record NCT02615262, source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)
- Primary completion: 2018-11 (actual) (ClinicalTrials.gov record NCT02615262, source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT02615262, source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)
- Countries: Brazil; China; Russia (ClinicalTrials.gov record NCT02615262, source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02615262-2018-12-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intraoperative Dexamethasone in Pediatric Cardiac Surgery
- Condition: Cardiac Surgery
- Condition: Congenital Heart Defects
- Condition: Cardiopulmonary Bypass
- Intervention (Drug): Dexamethasone
- Intervention (Drug): Placebo
- Lead sponsor: Meshalkin Research Institute of Pathology of Circulation
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Meshalkin Research Institute of Pathology of Circulation (`cardio:org-meshalkin-research-institute-of-pathology-of-circulation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Intraoperative Dexamethasone on Major Complications and Mortality Among Infants Undergoing Cardiac Surgery: The DECISION Randomized Clinical Trial (`cardio:pubmed-32573670`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 52d347ca13654b58ea85401ad54c156cb4a8365ce23fd688a2eb0f201ad1ad02
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
